Crick Katelynn, Thomson Denise, Fernandes Ricardo M, Nuspl Megan, Eurich Dean T, Rowe Brian H, Hartling Lisa
School of Public Health, University of Alberta, Edmonton, Canada.
4-498B Edmonton Clinic Health Academy, 11405 - 87 Avenue, Edmonton, AB, T6G 1C9, Canada.
BMC Pediatr. 2017 Jul 11;17(1):155. doi: 10.1186/s12887-017-0908-7.
Systematic reviews support health systems and clinical decision-making by identifying and summarizing all existing studies on a particular topic. In 2009, a comprehensive description of child-relevant systematic reviews published in the Cochrane Database of Systematic Reviews was compiled. This study aims to provide an update, and to describe these systematic reviews according to their content and methodological approaches.
All child-relevant systematic reviews published by the Cochrane Collaboration in the Cochrane Database of Systematic Reviews (CDSR) as of March, 2013 were identified and described in relation to their content and methodological approaches. This step equated to an update of the Child Health Field Review Register (CHFRR). The content of the updated CHFRR was compared to the published 2009 CHFRR description regarding clinical and methodological characteristics, using bivariate analyses. As the Cochrane Collaboration has recognized that disease burden should guide research prioritization, we extracted data from the Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013 study in order to map the distribution of the burden of disease in child health to the distribution of evidence across Review Groups in the CHFRR.
Of the 5,520 potential Cochrane systematic reviews identified, 1,293 (23.4%) were child-relevant (an increase of 24% since 2009). Overall, these reviews included 16,738 primary studies. The most commonly represented Review Groups were Airways (11.5%), Cystic Fibrosis and Genetic Diseases (7.9%), Acute Respiratory Infections (7.8%), Developmental, Psychological and Learning Problems (6.7%), and Infectious Diseases (6.2%). Corresponding authors were most often from Europe (51%), North America (15%), and Australia (15%). The majority of systematic reviews examined pharmacological interventions alone (52% compared to 59% in 2009). Out of 611 reviews that were assessed as up-to-date, GRADE was used in 204 (35%) reviews to assess the overall quality of the evidence, which was often moderate (35.6%) or low (37.8%) for primary outcomes. Ninety percent of reviews that were assessed as up to date used the Cochrane Risk of Bias tool, or a modified version, to assess methodological quality. Most reviews conducted one or more meta-analyses (73%). Among the 25 leading causes of death globally, the Review Groups associated with the largest number of causes were: 1) Infectious Diseases, 2) Anaesthesia, Critical, and Emergency Care, 3) Injuries, 4) Pregnancy and Childbirth (PC), and 5) Neonatal. There were large discrepancies between the number of causes of mortality that each Review Group was associated with and the total amount of evidence each Review Group contributed to the CHFRR. Ninety-eight percent of the causes of mortality in 2013 were from developing nations, but only 224 (17.3%) reviews had corresponding authors from developing countries.
The content and methodological characteristics of child-relevant systematic reviews in the Cochrane CHFRR have been described in detail. There were modest advances in methods between 2009 and 2013. Systematic reviews contained in the CDSR offer an important resource for researcher's, clinicians and policy makers by synthesizing an extensive body of primary research. Further content analysis will allow the identification of clinical topics of greatest priority for future systematic reviews in child health.
系统评价通过识别和总结关于特定主题的所有现有研究来支持卫生系统和临床决策。2009年,编制了一份发表在《Cochrane系统评价数据库》中与儿童相关的系统评价的全面描述。本研究旨在提供更新内容,并根据其内容和方法学方法描述这些系统评价。
识别截至2013年3月由Cochrane协作网在《Cochrane系统评价数据库》(CDSR)中发表的所有与儿童相关的系统评价,并根据其内容和方法学方法进行描述。这一步等同于更新儿童健康领域评价登记册(CHFRR)。使用双变量分析,将更新后的CHFRR内容与已发表的2009年CHFRR关于临床和方法学特征的描述进行比较。由于Cochrane协作网已认识到疾病负担应指导研究优先级确定,我们从《1990年至2013年儿童和青少年全球及国家疾病和伤害负担》研究中提取数据,以便将儿童健康领域疾病负担的分布与CHFRR中各评价组的证据分布进行映射。
在识别出的5520项潜在Cochrane系统评价中,1293项(23.4%)与儿童相关(自2009年以来增加了24%)。总体而言,这些评价纳入了16738项原始研究。最常出现的评价组是气道(11.5%)、囊性纤维化和遗传疾病(7.9%)、急性呼吸道感染(7.8%)、发育、心理和学习问题(6.7%)以及传染病(6.2%)。通讯作者大多来自欧洲(51%)、北美(15%)和澳大利亚(15%)。大多数系统评价仅考察了药物干预措施(52%,2009年为59%)。在611项被评估为最新的评价中,2者使用GRADE来评估证据的总体质量,对于主要结局,证据质量通常为中等(35.6%)或低(37.8%)。90%被评估为最新的评价使用Cochrane偏倚风险工具或其修改版本来评估方法学质量。大多数评价进行了一项或多项荟萃分析(73%)。在全球25种主要死因中,与最多死因相关的评价组为:1)传染病,2)麻醉、重症和急诊护理,3)伤害,4)妊娠和分娩(PC),以及5)新生儿。每个评价组相关的死亡原因数量与该评价组对CHFRR贡献的证据总量之间存在很大差异。2013年98%的死亡原因来自发展中国家,但只有224项(17.3%)评价的通讯作者来自发展中国家。
已详细描述了Cochrane CHFRR中与儿童相关的系统评价的内容和方法学特征。2009年至2013年期间方法学有适度进展。CDSR中包含的系统评价通过综合大量原始研究,为研究人员、临床医生和政策制定者提供了重要资源。进一步的内容分析将有助于确定儿童健康领域未来系统评价最优先的临床主题。